| Report ID | 278926 |
| Drug Identification Number | 00533688 |
| Brand name | TOBRAMYCIN FOR INJECTION |
| Common or Proper name | Tobramycin for Injection, USP 1.2 g, Vial |
| Company Name | FRESENIUS KABI CANADA LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | TOBRAMYCIN |
| Strength(s) | 1.2G |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 1.2g |
| ATC code | J01GB |
| ATC description | AMINOGLYCOSIDE ANTIBACTERIALS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | 2026-03-09 |
| Actual start date | |
| Estimated end date | 2026-03-23 |
| Actual end date | |
| Shortage status | Anticipated shortage |
| Updated date | 2026-02-25 |
| Company comments | Delay in production |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
| Company contact information |
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2026-02-25 | French | Compare |
| v1 | 2026-02-25 | English | Compare |
Showing 1 to 2 of 2